AstraZeneca Ethiopia announced today that it will work with The Ethiopian Federal Ministry of Health and The Ethiopian Thoracic Society, as part of their new Africa PUMUA Initiative, aimed at redefining asthma care in Africa.

The Initiative was launched in consultation and collaboration with the government, healthcare societies and respiratory health experts to strengthen local health systems and centres to get better pediatric and adult asthma management across both the public and private sectors.

The Africa PUMUA Initiative will strengthen fundamental changes needed to advance clinical practice aligned to the Non-Communicable Disease service decentralization program roll-out by the Ethiopian Federal Ministry of Health.

Globally, more than 339 million people are living with asthma, with an estimated over 40 million people with asthma in Africa. The World Health Organisation (WHO) cautions that over 80% of asthma-related deaths occur in low-and lower-middle-income countries.

AstraZeneca has launched the Africa PUMUA Initiative to highlight its commitment to improving the health outcomes of patients in Africa. By providing support of infrastructure, increasing awareness of the symptoms and risks of asthma, and building the capacity of all role players across the patient journey, the Africa PUMUA Initiative looks at addressing the barriers currently preventing access to care for patients with asthma.

As part of the partnership signed on 27 January 2021, with The Ethiopian Federal Ministry of Health and The Ethiopian Thoracic Society, AstraZeneca will provide 150 nebulizer machines to various hospitals within Ethiopia, as well as establishing 47 nebulization stations. The nebulizers will be allocated in consultation with the Ministry of Health and the Ethiopian Thoracic Society.

Biden's UN Ambassador Candidate Hedges On India's Security Council Seat

WHO team probing Covid-19 origin in China leaves Wuhan quarantine

Former ISI chief Durrani in touch with RAW since 2008, Pakistan claims